Back to results
US 8,263,071 B2Granted
Protein involved in ovarian cancer
AssigneeUCB Pharma S.A.
InventorNicola Anne Burgess
Life of this patent
Estimating the term…
Abstract
The present invention relates to new uses of CDCP1 in the diagnosis, screening, treatment and prophylaxis of ovarian cancer. The invention also provides compositions comprising CDCP1, including vaccines, antibodies that are immunospecific for CDCP1 and agents which interact with or modulate the expression or activity of CDCP1 or which modulate the expression of the nucleic acid which codes for CDCP1.
Claims3
A method for the treatment of ovarian cancer comprising administering a therapeutically effective amount of an anti-CDCP1 antibody which interacts with a CDCP1 polypeptide.
Dependencies are inferred from the claim text.